A study to compare spinal anesthesia in caesarean section when drug is given according to height and weight versus a fixed dose.
Not Applicable
- Conditions
- Health Condition 1: O82- Encounter for cesarean delivery without indication
- Registration Number
- CTRI/2022/04/042328
- Lead Sponsor
- Saveetha medical college hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patient undergoing elective LSCS
2) Age 18-40 yrs
3) ASA II patients
4) Weight 50-90 kg
5) Height 140cm-180cm
6) Singleton pregnancy
Exclusion Criteria
1) Emergency caesarean section
2) Patients refusing spinal anesthesia
3) Infection at the site of regional blockade
4) Bleeding diathesis
5) Hypersensitivity to the study drug
6) Allergy to local anaesthetics
7) Neurological diseases
8) Spinal deformities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does height/weight-based intrathecal bupivacaine dosing affect spinal block characteristics compared to fixed-dose regimens in C-sections?
What molecular mechanisms underlie differential spinal anesthesia efficacy with bupivacaine dosing based on patient anthropometrics?
Which biomarkers correlate with successful spinal block outcomes in CTRI/2022/04/042328's bupivacaine dosing comparison?
What adverse event profiles distinguish fixed-dose versus personalized intrathecal bupivacaine in obstetric spinal anesthesia?
How do alternative local anesthetic dosing strategies (e.g., ropivacaine) compare to bupivacaine in C-section spinal block efficacy?